SecSonar.com

Guardant Health, Inc. (GH)

Guardant Health, Inc. at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.

Guardant Health, Inc. (GH) is a Medical - Diagnostics & Research company based in US with a market capitalization of $17.2B. Revenue grew 32.9% year-over-year and free cash flow was negative at -$233.1M. This page tracks GH's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.

US · 2K employees · IPO Oct 4, 2018

Valuation

Valuation & price

$94.92 · as of May 17, 2026 · -44.4% vs 52w high

—

P/E ratio

Latest-FY diluted EPS

—

P/B ratio

Market cap ÷ book equity

—

Dividend yield

Price — last 12 months

$168$104$40.98Jul 25Dec 25Jul 26Jul 7, 25$49.54Jul 9, 25$51.04Jul 11, 25$50.25Jul 15, 25$48.09Jul 17, 25$47.28Jul 21, 25$45.64Jul 23, 25$45.45Jul 25, 25$44.42Jul 29, 25$43.32Jul 31, 25$40.98Aug 4, 25$44.19Aug 6, 25$44.59Aug 11, 25$54.80Aug 13, 25$58.57Aug 15, 25$58.88Aug 19, 25$58.57Aug 21, 25$61.28Aug 25, 25$61.88Aug 27, 25$63.50Aug 29, 25$67.42Sep 3, 25$65.06Sep 5, 25$60.13Sep 9, 25$59.44Sep 11, 25$56.80Sep 16, 25$55.40Sep 18, 25$58.80Sep 22, 25$59.78Sep 24, 25$57.67Sep 26, 25$60.03Sep 30, 25$62.48Oct 2, 25$61.46Oct 6, 25$63.38Oct 8, 25$65.32Oct 10, 25$64.22Oct 14, 25$62.56Oct 16, 25$67.47Oct 21, 25$67.51Oct 23, 25$69.35Oct 27, 25$70.85Oct 29, 25$72.27Oct 31, 25$93.02Nov 4, 25$98.14Nov 6, 25$96.25Nov 10, 25$97.92Nov 12, 25$97.84Nov 14, 25$94.37Nov 18, 25$95.57Nov 20, 25$100.30Nov 25, 25$108.81Nov 28, 25$108.42Dec 2, 25$103.87Dec 4, 25$108.52Dec 8, 25$104.17Dec 10, 25$102.62Dec 12, 25$102.07Dec 16, 25$100.00Dec 18, 25$97.10Dec 22, 25$101.34Dec 24, 25$102.38Dec 29, 25$101.39Jan 2, 26$101.74Jan 6, 26$112.33Jan 8, 26$108.74Jan 12, 26$107.57Jan 14, 26$108.60Jan 16, 26$112.14Jan 21, 26$115.75Jan 23, 26$114.75Jan 27, 26$114.59Jan 29, 26$110.48Feb 2, 26$114.90Feb 4, 26$106.15Feb 9, 26$105.34Feb 11, 26$107.58Feb 13, 26$104.85Feb 18, 26$107.42Feb 20, 26$103.10Feb 24, 26$95.40Feb 26, 26$97.97Mar 2, 26$92.23Mar 4, 26$93.02Mar 6, 26$91.20Mar 10, 26$90.49Mar 12, 26$84.02Mar 17, 26$88.75Mar 19, 26$89.08Mar 23, 26$84.96Mar 25, 26$86.58Mar 27, 26$84.61Mar 31, 26$92.37Apr 2, 26$93.83Apr 7, 26$93.30Apr 9, 26$87.17Apr 13, 26$82.21Apr 15, 26$84.86Apr 17, 26$90.36Apr 22, 26$89.56Apr 24, 26$88.91Apr 28, 26$83.09Apr 30, 26$87.08May 4, 26$91.17May 6, 26$92.25May 8, 26$95.70May 12, 26$99.94May 14, 26$98.66May 18, 26$95.66May 20, 26$114.97May 22, 26$118.95May 28, 26$133.22Jun 1, 26$129.14Jun 3, 26$127.03Jun 5, 26$125.61Jun 9, 26$130.12Jun 11, 26$130.90Jun 15, 26$129.82Jun 17, 26$129.11Jun 22, 26$128.83Jun 24, 26$136.96Jun 26, 26$149.22Jul 2, 26$167.98
$40.9852-week range$170.77
Loading valuation history…

Fundamentals

Key fundamentals

$17.2B

Market cap

32.9%

Revenue growth (YoY)

64.5%

Gross margin

-$233.1M

Free cash flow (USD)

$480.9M

Net debt

2.1%

Share dilution

1/4

Graham criteria passed

Defensive-investor screen

Healthcare

Sector

Trajectory

Long-term trends

Revenue by year

2016 → 2025

FY 2016$25.2MFY 2017$49.8MFY 2018$90.6MFY 2019$214.4MFY 2020$286.7MFY 2021$373.7MFY 2022$449.5MFY 2023$563.9MFY 2024$739.0MFY 2025$982.0M
$25.2M$982M

Free cash flow by year

2016 → 2025

FY 2016$-38.5MFY 2017$-81.2MFY 2018$-92.4MFY 2019$-68.4MFY 2020$-158.0MFY 2021$-284.1MFY 2022$-386.9MFY 2023$-345.5MFY 2024$-274.9MFY 2025$-233.1M
-$38.5M-$233.1M

Gross margin by year

2021 → 2025

FY 202167.1%FY 202265.2%FY 202359.7%FY 202460.8%FY 202564.5%
67.1%64.5%

Value screen

Graham defensive-investor tests

Computing the scorecard — refreshing any stale inputs…

0

Insider buys · 90 days

22

Insider sells · 90 days

Earnings

Last report: 10-Q filed May 7, 2026

Next expected: not yet scheduled

On the tape

Recent SEC & insider activity

  • Insider sellInsider Sell $157KKalia Kumud · Chief Information Officer · $157.2KJun 30, 2026Filing
  • Insider sellInsider Sell $39.3MTalasaz AmirAli · Director, Co-Chief Executive Officer · $39.3MJun 30, 2026Filing
  • Insider sellInsider Sell $204KPOTTER MYRTLE S · Director · $204.1KJun 23, 2026Filing
  • Insider sellInsider Sell $256KTariq Musa · Director · $255.9KJun 23, 2026Filing
  • 8-K eventAnnual Meeting ResultsJun 18, 2026Filing
  • Insider sellInsider Sell $15KTariq Musa · Director · $15.1KJun 16, 2026Filing
  • Insider sellInsider Sell $445KKalia Kumud · Chief Information Officer · $445.2KJun 15, 2026Filing
  • Insider sellInsider Sell $652KKalia Kumud · Chief Information Officer · $652KJun 12, 2026Filing
  • Insider sellInsider Sell $257KBell Michael Brian · Chief Financial Officer · $257.2KJun 8, 2026Filing
  • Insider sellInsider Sell $12.6MEltoukhy Helmy · Director, Co-Chief Executive Officer · $12.6MJun 8, 2026Filing

Questions

Frequently asked questions

What is Guardant Health, Inc.'s market cap?

Guardant Health, Inc. (GH) has a market capitalization of $17.2B.

What is GH's P/E ratio?

A meaningful P/E ratio is not available for GH — the company's latest fiscal-year earnings per share is zero, negative, or not yet cached.

Are insiders buying GH stock?

SEC Form 4 filings show no open-market insider buys at Guardant Health, Inc. in the last 90 days (22 sells).

Same arena

Related companies in Medical - Diagnostics & Research

LH

Labcorp Holdings Inc.

$21.5B

MEDP

Medpace Holdings, Inc.

$12.9B

DGX

Quest Diagnostics Incorporated

$21.6B

RVTY

Revvity, Inc.

$11.6B

MTD

Mettler-Toledo International Inc.

$23.8B

ICLR

ICON Public Limited Company

$10.5B

Timeline

Every filing, insider trade & earnings on a price-anchored timeline

Filing Analyzer

Search the actual 10-K / 10-Q text with AI research angles

News

Latest press coverage in one feed

Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.